TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome: The discovery of TRPM3 as a nociceptor channel substantially targeted by certain opioid receptors, as well as its implication in Ca2+-dependent NK cell immune functions suggests that TRPM3 ion channel may be pharmacologically targeted to treat ME/CFS.